Pseudohyperplastic prostatic adenocarcinoma

American Journal of Surgical Pathology

Volumn 22, Issue 10, 1998, Pages 1239-1246

  Humphrey, Peter A ^a,c   Kaleem, Zahid ^a   Swanson, Paul E ^a   Vollmer, Robin T ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

Author keywords

Carcinoma; Hyperplasia; Prostate; Prostate neoplasms

Indexed keywords

ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATECTOMY; TUMOR VOLUME;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATINS; MALE; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0031658276     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199810000-00009     Document Type: Article

References (45)

1. Ackerman LV. Surgical Pathology. St. Louis: CV Mosby; 1964:651.
2. Ackerman LV, Rosai J. The pathology of tumors, part one. Introduction, precancerous lesions, benign lesions that resemble cancer. CA Cancer J Clin 1971;21163-73.
3. Alguacil-Garcia A. Artifactual changes mimicking signet ring cell carcinoma in transurethral prostatectomy specimens. Am J Surg Pathol 1986;10:795-800.
4. Andrews GS. Latent carcinoma of the prostate. J Clin Pathol 1949; 2:197-208.
5. Arista-Nasr J, Cortes E, Pichardo R. Low grade adenocarcinoma simulating benign glandular lesions in needle prostatic biopsy. Rev Invest Clin 1997;49:37-40.
6. Ayala AG, Srigley JR, Ro JY, Abdul-Karim FW, Johnson DE. Clear cell cribriform hyperplasia of prostate. Report of 10 cases. Am J Surg Pathol 1986;10:665-671.
7. Bostwick DG, Dundore PA. Biopsy Pathology of the Prostate. New York: Chapman and Hall Medical: 1997;108, 111, 123, 125.
8. Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated. Hum Pathol 1993;24:819-32.
9. Cinha SJ, Epstein JI. Adenocarcinoma of the prostate with atrophic features. Am J Surg Pathol 1997;21:287-95.
10. Egan AJM, Lopez-Beltran A, Bostwick DG. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process. Am J Surg Pathol 1997;21:931-935.
11. Epstein JI. Prostate adenocarcinomas resembling benign glands vs. benign prostate glands. In: Differential Diagnosis in Pathology: Urologic Disorders. New York: Igaku-Shoin; 1992:106-7.
12. Epstein JI. Adenosis. In: Prostate Biopsy Interpretation. Philadelphia: Lippincott-Raven; 1995:146-163.
13. Epstein JI. Evaluation of transurethral resection specimens. In: Prostate Biopsy Interpretation. Philadelphia: Lippincott-Raven, 1995:143-4.
14. Epstein JI, Hutchins GM. Granulomatous prostatitis. Distinction among allergic, non-specific, and post-transurethral resection lesions. Hum Pathol 1984;15:818-25.
15. Epstein JI, Murphy WM. Diseases of the prostate gland and seminal vesicles. In: Murphy WM, ed. Urological Pathology. Philadelphia: WB Saunders; 1997:148-241.
16. Franks LM. Latent carcinoma of the prostate. J Pathol Bacteriol 1954;68:603-16.
17. Franks LM. Benign nodular hyperplasia of the prostate: a review. Ann R Coll Surg Engl 1954;14:92-106.
18. Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol 1994; 17:863-70.
19. Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol 1995;19:737-47.
20. Gleason DF, and the Veterans Administration Cooperative Urological Research Group. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, ed. Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger; 1977:171-97.
21. Humphrey PA, Baty J, Keetch D. Relationship between serum prostate-specific antigen, needle biopsy findings, and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Cancer 1995;75:1842-9.
22. Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol 1990;21:799-804.
23. Kaleem Z, Swanson PE, Vollmer RT, Humphrey PA. Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive, completely-embedded radical prostatectomy specimens. Am J Clin Pathol 1998;109:695-703.
24. McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol 1978;15:340-5.
25. Moore RA. The morphology of small prostatic carcinoma. J Urol 1935;33:224-34.
26. Mostofi FK, Sesterhenn IA, Davis CJ Jr. A pathologist's view of prostatic carcinoma. Cancer 1993;71:906-32.
27. Muir EG. Carcinoma of the prostate. Lancet 1934;1:667-672.
28. Nelson RS, Epstein JI. Prostatic carcinoma with abundant xanthomatous cytoplasm: foamy gland carcinoma. Am J Surg Pathol 1996;20:419-26.
29. Noether GE, ed. Introduction to Statistics. The Nonparametric Way. New York: Springer-Verlag, 1990.
30. Presti B, Weidner N. Granulomatous prostatitis and poorly differentiated adenocarcinoma. Their distinction with the use of immunohistochemical methods. Am J Clin Pathol 1991;95:330-4.
31. Reuter VE. Pathological changes in benign and malignant tissue following androgen deprivation therapy. Urology 1997;49(suppl 5):16-22.
32. Ro JY, El-Naggar A, Ayala AG, Mody DR, Ordonez NG. Signetring cell carcinoma of the prostate. Electron-microscopic and immunohistochemical study of eight cases. Am J Surg Pathol 1988; 12:453-60.
33. Ro JY, Grignon DJ, Amin MB, Ayala A. Atlas of Surgical Pathology of the Male Reproductive Tract. Philadelphia: WB Saunders; 1997:69-70.
34. S-plus guide to statistical and mathematical analysis. Seattle: Statistics division of MathSoft, 1995.
35. Sebo TJ, Bostwick DG, Farrow GM, et al. Prostatic xanthoma: a mimic of prostatic adenocarcinoma. Hum Pathol 1994;25:386-9.
36. Segawa T, Kahehi Y. Primary signet-ring cell adenocarcinoma of the prostate: a case report and literature review. Acta Urol J 1993; 39:565-8.
37. Srigley JR. Small acinar patterns in the prostate gland with emphasis on atypical adenomatous hyperplasia and small acinar carcinoma. Semin Diagn Pathol 1988;5:254-72.
38. Totten RS, Heinemann MW, Hudson PB, Sproul EE, Stout AP. Microscopic differential diagnosis of latent carcinoma of the prostate. Arch Pathol 1953;55:131-41.
39. Venables WN, Ripley BB. Modern Applied Statistics with S-plus. New York: Springer Verlag; 1994.
40. Weidner N, guest ed. Malignant lesions that mimic benign tumors. Semin Diagn Pathol 1995;12:1-104.
41. Wick MR, Humphrey PA, Ritter JH, eds. Pathology of Pseudoneoplastic Lesions. New York: Lippincott-Raven: 1997.
42. Willis RA. Pathology of Tumors. St. Louis: CV Mosby; 1948:587.
43. Young RH. Pseudoneoplastic lesions of the prostate gland. Pathol Annu 1988;23(pt 1):105-28.
44. Young RH. Tumor-like lesions of the prostate gland. Am J Clin Pathol 1997;104:607-10.
45. Young RH. Pseudoneoplastic lesions of the urinary bladder, prostate gland, and urethra. In: Wick MR. Humphrey PA, Ritter JR, eds. Pathology of Pseudoneoplastic Lesions. New York: Lippincott-Raven; 1997:223-35.